The A1CNow Selfcheck, which can be used by diabetes patients to check their A1C level at home in between doctor visits, has been developed in the US.
A1CNow Selfcheck enables patients to more closely look at their A1C level between doctor visits and allow them to have a more informed discussion with their doctor to ensure their diabetes plan is working.
The system, cleared by the Food and Drug Administration in 2009, complements the healthcare provider-administered A1C test but is not intended to replace it or routine blood glucose testing.
The system manufactured by Bayer Diabetes Care comes as a two-test-kit, which costs $29.99.
Measuring A1C levels is important for long-term diabetes management, as even a 1% point reduction in A1C may lower the risk of complications by up to 40%.